CXCL14 and urinary bladder carcinoma: Western blot analysis revealed that deficient expression of CXCL14 in CAFs failed to increase the expression of ERCC4 and inhibited DNA damage-induced apoptosis in bladder cancer cells (Fig. 3J, M).